Trial intelligence / Profile preview

Body Weight Response With Disulfiram in Humans

NCT05162001Phase 1Unknown

Sponsor
Universidad de Guanajuato
Start
Nov 2021
Primary completion
Jan 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label, single-arm trial of disulfiram in obesity, sponsored by Universidad de Guanajuato. Primary endpoint: Body weight change at 9 weeks. Status: unknown.

02

Drugs

disulfiram
03

Conditions

obesity

Beyond the preview

Go deeper on NCT05162001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05162001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call